Yayın:
Pharmacophore‐Based Modeling, Synthesis, and Biological Evaluation of Novel Quinazoline/Quinoline Derivatives: Discovery of EGFR Inhibitors with Low Nanomolar Activity

dc.contributor.authorEVREN, ASAF EVRİM
dc.contributor.authorAkalın-Çiftçi, Gülşen
dc.contributor.authorSAĞLIK ÖZKAN, BEGÜM NURPELİN
dc.contributor.authorYURTTAŞ, LEYLA
dc.contributor.orcid0000-0002-8651-826X
dc.contributor.orcid0000-0002-0151-6266
dc.contributor.orcid0000-0002-0957-6044
dc.date.accessioned2025-11-13T11:12:32Z
dc.date.issued2024-10-18
dc.identifier.doihttps://doi.org/10.1002/adts.202400811
dc.identifier.issn2513-0390
dc.identifier.issue1
dc.identifier.openalexW4403540032
dc.identifier.urihttps://hdl.handle.net/11421/6047
dc.identifier.urihttps://doi.org/10.1002/adts.202400811
dc.identifier.volume8
dc.language.isoen
dc.relation.ispartofAdvanced Theory and Simulations
dc.rightsrestrictedAccess
dc.subjectPharmacophore
dc.subjectQuinoline
dc.subjectDrug discovery
dc.subjectQuinazoline
dc.subjectCombinatorial chemistry
dc.subjectChemistry
dc.subjectBiological activity
dc.subjectComputational biology
dc.subjectPharmacology
dc.subjectStereochemistry
dc.subjectBiochemistry
dc.subjectBiology
dc.subjectIn vitro
dc.subjectOrganic chemistry
dc.subject.sdg3
dc.titlePharmacophore‐Based Modeling, Synthesis, and Biological Evaluation of Novel Quinazoline/Quinoline Derivatives: Discovery of EGFR Inhibitors with Low Nanomolar Activity
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5008980400
local.authorid.openalexA5023915146
local.authorid.openalexA5074136342
local.authorid.openalexA5090129265

Dosyalar

Koleksiyonlar